BMA rejects NICE statin proposalThe article reports on the move of the British Medical Association (MBA) to reject the proposal of the National Institute for Health and Care Excellence (NICE) to offer statins for primary prevention to millions ...
tinsforprimarypreventionofcardiovasculardiseases[J].ChinJCa rdiovascMed,2022,27(3):215-218. [24]KimBK,HongSJ,LeeYJ,etal.Long-termefficacyandsafe tyofmoderate-intensitystatinwithezetimibecombinationtherapyve rsushigh-intensitystatinmonotherapyinpatientswithatherosclerot iccardiovasculardisease(RACING):arandomised...
The NICE guidance specifically recommends that GPs start statin treatment for the primary prevention of CVD with atorvastatin 20mg while patients with established CVD, type 1 diabetes or type 2 diabetes should be offered a higher strength 80mg dose of atorvastatin. However, NICE also acknowledges not...
tinsforprimarypreventionofcardiovasculardiseases[J].ChinJCa rdiovascMed,2022,27(3):215-218. [2]KimBK,HongSJ,LeeYJ,etal.Long-termefficacyandsafe tyofmoderate-intensitystatinwithezetimibecombinationtherapyve rsushigh-intensitystatinmonotherapyinpatientswithatherosclerot iccardiovasculardisease(RACING):arandomised...
Statin therapy is recommended as part of the management strategy for primary prevention of CVD among adults with at least a 20% 10-year risk of developing CVD; treatment should be initiated with simvastatin 40mg. For the secondary prevention of CVD , drugs to reduce cholesterol levels should be...
Statin therapy for the primary prevention of cardiovascular disease(CVD)has been recommended by the National Institute for Health and Clinical Excellence for adults who have a 20 per cent or greater 10-year risk of developing CVD.Guidance published this week also recommends statins for adults with ...
welcome and summarised in this issue of Heart.2 NICE recommends its use in combination with a statin when more intensive low-density lipoprotein (LDL) lowering is indicated, and as monotherapy in the small proportion of patients who are intolerant of statin or in whom a statin is ...